Excelsior Medical Co., Ltd. (TPE:4104)

Excelsior Medical Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	4,189	2,615	2,507	3,072	2,618
Short-Term Investments	757.57	768.17	721.62	699.4	936.17
Cash & Short-Term Investments	4,947	3,383	3,229	3,772	3,555
Cash Growth	46.23%	4.78%	-14.40%	6.11%	4.16%
Accounts Receivable	2,183	2,279	2,031	1,908	1,630
Other Receivables	3,424	3,536	2,998	2,567	2,309
Receivables	5,607	5,815	5,029	4,475	3,940
Inventory	1,393	1,247	1,161	910.24	851.24
Other Current Assets	274.37	246.77	109.55	150.59	156.39
Total Current Assets	12,221	10,692	9,528	9,308	8,502
Property, Plant & Equipment	1,121	1,071	1,028	914.16	834.31
Long-Term Investments	4,907	4,917	4,536	3,558	3,373
Goodwill	28.95	28.25	27.76	27.39	27.85
Other Intangible Assets	18.18	16.91	3.87	5.62	4.8
Long-Term Deferred Tax Assets	108.56	137	158.75	202.41	215.49
Other Long-Term Assets	1,679	1,159	1,168	1,072	1,036
Total Assets	20,368	18,080	16,483	15,105	14,005
Accounts Payable	978.97	974.73	1,000	947.53	882.27
Accrued Expenses	4,606	2,961	2,739	2,254	1,529
Short-Term Debt	917.53	1,135	535.13	479.97	404.5
Current Portion of Long-Term Debt	-	-	-	-	4.25
Current Portion of Leases	128.34	69.97	90.86	72.24	78.37
Current Income Taxes Payable	101.22	143.37	98.44	63.88	63.89
Current Unearned Revenue	543.6	559.17	484.94	379.22	311.98
Other Current Liabilities	1,013	835.21	803.35	758.56	745.94
Total Current Liabilities	8,289	6,679	5,752	4,955	4,020
Long-Term Debt	2.68	0.58	0.53	-	-
Long-Term Leases	377.83	236.83	182.05	209.78	225.46
Long-Term Deferred Tax Liabilities	322.49	235.07	233.8	176.7	156.96
Other Long-Term Liabilities	14.63	6.85	7.39	5.31	5.33
Total Liabilities	9,011	7,167	6,185	5,359	4,425
Common Stock	1,634	1,556	1,482	1,411	1,411
Additional Paid-In Capital	3,383	3,288	3,276	3,276	3,276
Retained Earnings	3,620	3,503	3,344	3,193	3,017
Comprehensive Income & Other	333.49	266.66	97.49	-142.1	-114.08
Total Common Equity	8,970	8,613	8,200	7,738	7,591
Minority Interest	2,387	2,300	2,097	2,007	1,989
Shareholders' Equity	11,357	10,913	10,297	9,746	9,580
Total Liabilities & Equity	20,368	18,080	16,483	15,105	14,005
Total Debt	1,426	1,442	808.58	761.99	712.58
Net Cash (Debt)	3,520	1,941	2,420	3,010	2,842
Net Cash Growth	81.40%	-19.81%	-19.59%	5.90%	45.76%
Net Cash Per Share	21.46	11.83	14.74	18.32	17.36
Filing Date Shares Outstanding	163.4	163.4	163.4	163.4	163.4
Total Common Shares Outstanding	163.4	163.4	163.4	163.4	163.4
Working Capital	3,932	4,013	3,776	4,353	4,482
Book Value Per Share	54.90	52.71	50.19	47.36	46.46
Tangible Book Value	8,923	8,568	8,169	7,705	7,558
Tangible Book Value Per Share	54.61	52.44	49.99	47.16	46.26
Land	144.51	137.82	144.18	140.67	145.11
Buildings	238.28	226.57	258.16	250.73	262.34
Machinery	1,103	1,028	915.04	811.13	632.33
Construction In Progress	39.02	24.55	31.58	5.05	0.29
Leasehold Improvements	15.73	10.66	1.77	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.